Embleema

About:

Accelerating the availability of new treatments to the 350 million rare disease sufferers around the world.

Website: https://www.embleema.com

Twitter/X: embleema

Top Investors: Techstars, MassChallenge, Pharmagest

Description:

We empower patients to reclaim ownership of their medical data, connect directly with research studies, and be compensated for sharing their data. We are setting the standard for Real World Evidence, an achievement that will substantially reduce the amount of time and costs for new life-saving drugs to reach patients with rare diseases. By improving the collection, quality and sharing of RWE, we enable the healthcare system to move away from the current linear process of drug approvals to a new iterative model where trustworthy digital health data is shared in real time between patients, manufacturers and regulators. Want to find out more? Get in touch!